Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin

Background. Direct-acting antiviral agents against HCV with or without peginterferon plus ribavirin result in higher eradication rates of HCV and shorter treatment duration. We examined which is better for predicting persistent virologic response, the assessment of serum HCV RNA at 12 or 24 weeks af...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanda, Tatsuo, Nakamoto, Shingo, Sasaki, Reina, Nakamura, Masato, Yasui, Shin, Haga, Yuki, Ogasawara, Sadahisa, Tawada, Akinobu, Arai, Makoto, Mikami, Shigeru, Imazeki, Fumio, Yokosuka, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829545/
https://www.ncbi.nlm.nih.gov/pubmed/27076789
http://dx.doi.org/10.7150/ijms.14953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829545/
https://www.ncbi.nlm.nih.gov/pubmed/27076789
http://dx.doi.org/10.7150/ijms.14953

Ejemplares similares